The biotech sector has always held a special appeal for risk-tolerant investors. While these companies face high overhead in the form of towering R......

Morgan Stanley analyst Maxwell Skor maintained a Buy rating on Cytokinetics today and set a price target of $75.85. Skor covers the Healthcare sect......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amylyx Pharmaceuticals Inc (AMLX), Strata Critical M......

Cytokinetics ( ($CYTK) ) has shared an announcement. On May 5, 2026, Cytokinetics released an updated corporate presentation outlining the commerci......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Disc Medicine (IRON) and Cytokineti......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Repligen (RGEN), Disc Medicine (IRON) and Cytokineti......

Traders will find the top stock market stories for Tuesday in our daily roundup. ...

Cytokinetics stock was up on Tuesday after a Phase 3 clinical trial met its primary endpoints. ...

Insiders have been trading these 5 stocks: (($WU)), (($CYTK)), (($FIX)), (($ACI)) and (($ASX)). Here is a breakdown of their recent trades and thei......